483
Aspire Houston Fertility InstituteAspire Houston Fertility Institute – FDA 483, Feb 6, 2020
Record Details
Aspire Fertility in Houston, TX was inspected from February 5-6, 2020, regarding its human reproductive tissue operations. The inspection revealed a significant lapse in donor screening procedures, specifically the failure to perform physical examinations for directed semen donors to screen for communicable disease agents. This indicates a potential risk related to the safety of human reproductive tissue.
- Office
- Dallas District Office
- Person
View Company Profile
ID · 298011ba-b30e-4c82-874e-e3c38f7e43ad
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.